Progress in cardiac electrophysiology and arrhythmias;Novedades en electrofisiología cardiaca y arritmias

Revista Espanola de Cardiologia

Volumn 64, Issue SUPPL. 1, 2011, Pages 81-90

  Hernández Madrid, Antonio ^a   Matía Francés, Roberto ^a   Moro, Concepción ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Atrial fibrillation; Catheter ablation; Electrophysiology; Implantable cardioverter defibrillator

Indexed keywords

ARTICLE; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; INVASIVE PROCEDURE;

ARRHYTHMIAS, CARDIAC; CARDIOLOGY; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC STIMULATION THERAPY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; MONITORING, PHYSIOLOGIC; SYNCOPE;

EID: 79251578697     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(11)70011-2     Document Type: Article

References (61)

1. A. Moya, R. Sutton, F. Ammirati, J.J. Blanc, M. Brignole, and J.B. Dahm Guidelines for the diagnosis and management of syncope (versión 2009) Eur Heart J 30 2009 2631 2671
2. P. Flevari, D. Leftheriotis, C. Komborozos, K. Fountoulaki, N. Dagres, and G. Theodorakis Recurrent vasovagal syncope: comparison between clomipramine and nitroglycerin as drug challenges during head-up tilt testing Eur Heart J 30 2009 2249 2253
3. V. Bazan, E. Rodríguez Font, X. Viñolas, J.M. Guerra, J. Bruguera Cortada, and J. Martí-Almor Taquicardia auricular de vena pulmonar: características clínicas, electrocardiográficas y electrofisiológicas diferenciales Rev Esp Cardiol 63 2010 149 155
4. B. Benito, J. Brugada, R. Brugada, and P. Brugada Síndrome de Brugada Rev Esp Cardiol 62 2009 1297 1315
5. C. Pappone, A. Radinovic, F. Manguso, G. Vicedomini, S. Sala, and F. Sacco New onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance Eur Heart J 30 2009 2985 2992
6. S. Richter, A. Sarkozy, G. Paparella, S. Henkens, T. Boussy, and G.B. Chierchia Number of electrocardiogram leads displaying the diagnostic coved-type pattern in Brugada syndrome: a diagnostic consensus criterion to be revised Eur Heart J 31 2010 1357 1364
7. J.D. Kapplinger, D.J. Tester, M. Alders, B. Benito, M. Berthet, and J. Brugada An international compemdium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing Heart Rhythm 7 2010 33 46
8. M. García-Castro, C. García, J. Reguero, A. Miar, J. Rubin, and V. Alvarez Espectro mutacional del gen SCN5A en pacientes españoles con síndrome de Brugada Rev Esp Cardiol 63 2010 856 859
9. J.R. Gimeno, M. Oliva, J. Lacunza, A. Alberola, M. Sabater, and J. Martínez-Sanchez Características de la muerte súbita en las cardiopatías hereditarias Rev Esp Cardiol 63 2010 268 276
10. J.D. Kapplinger, D.J. Tester, B.A. Salisbury, J.L. Carr, C. Harris-Kerr, and G.D. Pollevick Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test Heart Rhythm 6 2009 1297 1303
11. A. Natale, A. Raviele, A. Al-Ahmad, O. Alfieri, E. Aliot, and J. Almendral Venice Chart International Consensus Document on Ventricular Tachycardia/Ventricular Fibrillation Ablation J Cardiovasc Electrophysio 21 2010 339 379
12. A. Viana Tejedor, J.L. Merino, A. Silva, R. Cozar León, S. Moreno, and E. Díaz Carballo Resultados de la ablación con catéter de la taquicardia ventricular en pacientes ancianos con cardiopatía estructural Rev Esp Cardiol 63 2010 156 160
13. K.H. Kuck, A. Schaumann, L. Eckardt, S. Willems, R. Ventura, and E. Delacrétaz Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial Lancet 375 2010 31 40
14. F. Sacher, K. Roberts-Thomson, P. Maury, U. Tedrow, I. Nault, and D. Steven Epicardial Ventricular Tachycardia Ablation: A Multicenter Safety Study J Am Coll Cardiol 55 2010 2366 2372
15. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation. Eur Heart J. 2010; August 29. doi: 10.1093/ eurheartj/ehq278. Published ahead of print.
16. A. Macías, E. Díaz-Infante, and I. García-Bolao Registro Español de Ablación con Catéter. VIII Informe Oficial de la Sección de Electrofisiología y Arritmias de la Sociedad Española de Cardiología (2008) Rev Esp Cardiol 62 2009 1276 1285
17. C. De Vos, R. Pisters, R. Nieuwlaat, M. Prins, R. Tieleman, and R. Coelen Progression from paroxysmal to persistent atrial fibrillation: clinical correlates and prognosis J Am Coll Cardiol 55 2010 725 731
18. D.F. Gudbjartsson, H. Holm, S. Gretarsdottir, G. Thorleifsson, G.B. Walters, and G. Thorgeirsson A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke Nat Genet 41 2009 876 878
19. P.K. Mason, and J.P. DiMarco New pharmacological agents for arrhythmias Circ Arrhythm Electrophysiol 2 2009 588 597
20. S.H. Hohnloser, H.J. Crijns, M. Van Eickels, C. Gaudin, R.L. Page, and C. Torp-Pedersen Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
21. J.Y. Le Heuzey, G.M. De Ferrari, D. Radzik, M. Santini, J. Zhu, and J.M. Davy A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: The DIONYSOS Study J Cardiovasc Electrophysiol 21 2010 597 605
22. I.C. Van Gelder, H.F. Groenveld, H.JGM. Crijns, Y.S. Tuininga, J.GP. Tijssen, A.M. Alings for the RACE II Investigators Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 362 2010 1363 1373
23. L. Pérez de Isla, A. Bayes-Genis, J. Sanchis, and M. Heras Resumen de los ensayos clínicos presentados en las sesiones científicas anuales del American College of Cardiology Rev Esp Cardiol 63 2010 695 707
24. S. Connolly, M. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh The RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation NEJM 361 2009 1139 1151
25. R.S. Epstein, T.P. Moyer, R.E. Aubert, D.J. O Kane, F. Xia, and R.R. Verbrugge Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study) J Am Coll Cardiol 55 2010 2813 2815
26. D.R. Holmes, V.Y. Reddy, Z.G. Turi, S.K. Doshi, H. Sievert, M. Buchbinder PROTECT AF Investigators Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
27. C. Pappone, and V. Santinelli Ablación de la fibrilación auricular: ¿Dónde estamos? Rev Esp Cardiol 62 2009 1087 1091
28. R. Cappato, H. Calkins, S.A. Chen, W. Davies, Y. Iesaka, and J. Kalman Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation Circ Arrhythm Electrophysiol 3 2010 32 38
29. M.D. O'Neill, M. Wright, S. Knecht, P. Jaïs, M. Hocini, and Y. Takahashi Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint Eur Heart J 30 2009 1105 1112
30. T. Datino, L. Macle, X.Y. Qi, A. Maguy, P. Comtois, and D. Chartier Mechanisms by which adenosine restores conduction in dormant canine pulmonary veins Circulation 121 2010 963 972
31. D.J. Wilber, C. Pappone, P. Neuzil, A. De Paola, F. Marchlinski, and A. Natale Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation JAMA 303 2010 333 340
32. Day JD, Crandall BG, Osborn JS. Catheter ablation of atrial fibrillation reduces the risk of Alzheimer's disease and dementia. Heart Rhythm Society 2010 Scientific Sessions; May 13, 2010; Denver, CO.
33. T.J. Bunch, J.P. Weiss, B.G. Crandall, H.T. May, T.L. Bair, and J.S. Osborn Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia Heart Rhythm 7 2010 433 437
34. Chun KR, Wissner E, Koektuerk B, Konstantinidou M, Schmidt B, Zerm T, et al. Remote controlled magnetic pulmonary vein isolation utilizing a new irrigated tip catheter in patients with atrial fibrillation. Circulation. 2010 [Published online ahead of print].
35. C. Herrera, J. Minners, M. Allgeier, H. Allgeier, N. Jander, and R. Weber Cryoballoon pulmonary vein isolation guided by transesophageal echocardiography: novel aspects on an emerging ablation technique J Cardiovasc Electrophysiol 20 2009 1197 1202
36. C. Scharf, L. Boersma, W. Davies, P. Kanagaratnam, N.S. Peters, and V. Paul Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy J Am Coll Cardiol 54 2009 1450 1456
37. O. Wazni, C. Barrett, D. Martin, M. Shaheen, K. Tarakji, and B. Baranowski Experience with the hansen robotic system for atrial fibrillation ablation-lessons learned and techniques modified: Hansen in the real world J Cardiovasc Electrophysiol 20 2009 1193 1196
38. E. Arana, A. Pedrote, M. Frutos-López, L. Garcia-Riesco, A. Jiménez-Velasco, and J.A. Sánchez- Brotons Cartografía electroanatómica del esófago en el aislamiento circunferencial de venas pulmonares Rev Esp Cardiol 62 2009 1189 1192
39. A. Rillig, U. Meyerfeldt, R. Birkemeyer, S. Wiest, B. Sauer, and M. Staritz Oesophageaal temperature monitoring and incidence of oesophageal lesions after pulmonary vein isolation using a remote robotic navigation system Europace 12 2010 655 661
40. P. Peinado, E. Torrecilla, J. Ormaetxe, M. Álvarez, R. Cózar, J. Alzueta En representación del Grupo de Trabajo de Desfibrilador Implantable Registro Español de Desfibrilador Automático Implantable. V Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2008) Rev Esp Cardiol 62 2009 1435 1449
41. J. Vijgen, G. Botto, J. Camm, C.J. Hoijer, W. Jung, and J.Y. Le Heuzey Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators Europace 11 2009 1097 1107
42. Padeletti L, Arnar DO, Boncinelli L, Brachman J, Camm JA, Daubert JC, et al. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace. 2010 Jul 30 [Epub ahead of print].
43. R.P. Kelly, K.J. Buth, and J. Légaré Underutilization of implantable cardioverter-defibrillators after coronary artery bypass grafting in patients with impaired left ventricular function Can J Cardiol 25 2009 122b
44. G. Steinbeck, D. Andresen, K. Seidl, J. Brachmann, E. Hoffmann, and D. Wojciechowski Defibillator implantation early after myocardial infarction N Engl J Med 361 2009 1427 1436
45. M. Gasparini, C.C. Menozzi, A. Proclemer, M. Landolina, S. Lacopino, and A. Carboni A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non ischemic cardiomyopathy implanted for primary prevention: the RELEVANT study Eur Heart J 30 2009 2758 2767
46. M. Gasparini, F. Anselme, J. Clementy, M. Santini, J. Martínez-Ferrer, and T. DeSanto Biventricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D trial Am Heart J 159 2010 1116 1132
47. Wilkoff BL, Johnson JW, Ousdigian KT. Programming strategies associated with shock reduction in 88 804 implantable defibrillator patients. Heart Rhythm 2010 Scientific Sessions; May 13, 2010; Denver,CO.
48. J. Toquero, J. Alzueta, L. Mont, I.F. Lozano, A. Barrera, and A. Berruezo Morphology discrimination criterion wavelet improves rhythm discrimination in singlechamber implantable cardioverter-defibrillators: Spanish Register of morphology discrimination criterion wavelet (REMEDIO) Europace 11 2009 727 733
49. M. Sweeney, L. Sherfesee, P. De Groot, M. Wathen, and B. Wilkoff Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter defibrillator patients Heart Rhythm 7 2010 353 360
50. F. Buendia, J. Sánchez-Gómez, M.J. Sancho-Tello, J. Olague, J. Osca, and O. Cano Resonancia magnética nuclear en pacientes portadores de dispositivos de estimulación cardiaca Rev Esp Cardiol 63 2010 735 739
51. G.H. Bardy, W.M. Smith, M.A. Hood, I.G. Crozier, I.C. Melton, and L. Jordaens An entirely subcutaneous implantable cardioverter-defibrillator N Engl J Med 363 2010 36 44
52. K. Dickstein, N. Bogale, S. Priori, A. Auricchio, J.G. Cleland, and A. Gitt The European cardiac resynchronization therapy survey Eur Heart J 30 2009 2450 2460
53. C. Daubert, M.R. Gold, W.T. Abraham, S. Ghio, C. Hassager, G. Goode REVERSE study group Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the
54. A.J. Moss, W.J. Hall, D.S. Cannom, H. Klein, M.W. Brown, J.P. Daubert MADIT-CRT Trial Investigators Cardiac-resynchronization therapy for the prevention of heartfailure events N Engl J Med 361 2009 1329 1338
55. J. Sutton, S. Ghio, T. Plappert, L. Tavazzi, L. Scelsi, and C. Daubert Resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) Study group. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with NYHA class I/II heart failure Circulation 120 2009 1858 1865
56. C.M. Yu, J.Y. Chan, Q. Zhang, R. Omar, G.W. Yip, and A. Hussin Biventricular pacing in patients with bradycardia and normal ejection fraction N Engl J Med 361 2009 2123 2134
57. M. Sitges, B. Vidal, V. Delgado, L. Mont, A. Garcia-Alvarez, and J.M. Tolosana Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation Am J Cardiol 104 2009 383 388
58. J. Rickard, D.J. Kumbhani, Z. Popovic, D. Verhaert, M. Manne, and D. Sraow Characterization of super-response to cardiac resynchronization therapy Heart Rhythm 7 2010 885 889
59. D. Tamborero, L. Mont, M. Sitges, E. Silva, A. Berruezo, and B. Vidal Optimization of the interventricular delay in cardiac resynchronization therapy using the QRS width Am J Cardiol 104 2009 1407 1412
60. M. Brignole, P. Vardas, E. Hoffman, H. Huikuri, A. Moya, and R. Ricci Indications for the use of diagnostic implantable and external ECG loop recorders Europace 11 2009 671 687
61. G. Hindricks, E. Pokushalov, L. Urban, M. Taborsky, K. Kuck, and D. Lebedev Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation. Results of the XPECT trial Circ Arrhythm Electrophysiol 3 2010 141 147